Method for proliferating avian influenza viruses in bioreactor with cell carrier
An avian influenza virus and bioreactor technology, which is applied in the biological field, can solve problems such as large-scale vaccine production of unseen avian influenza viruses, and achieve the effects of improving purity and safety, realizing automatic control and uniform products.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0022] Reagents used: MDCK cells were purchased from ATCC library, and microcarrier Cytodex1 was purchased from Pharmacia Biotech AB Uppsala Sweden (batch number: 223429).
[0023] After swelling per gram of Cytodex1 (dry powder), the surface area is 4400cm 2 , the amount of microcarriers is 5-10g / L. Cell density in the reactor=4400×10×166666 / 1000=7.3×106 cells / ml. The density of inoculated MDCK cells was 6.6×106 cells / ml. The H9N2 avian influenza virus was diluted 1:1000 times with DMEN medium containing 0.025 concentration of trypsin and inoculated into the cells. After 1 hour of adsorption, it was cultured in serum-free DMEN medium. Harvest the virus, harvest the virus liquid with 50% of the liquid exchange volume, harvest the virus liquid completely in 48 hours, and stop the bioreactor cultivation. Culture parameters: Stirring speed 40 rev / min: Dissolved oxygen reaches ±50% during the cell growth period, and ±40% during the cell expression period. Ventilation: The vent...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com